These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3840854)

  • 21. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy.
    Nagayama Y; Izumi M; Kiriyama T; Yokoyama N; Morita S; Kakezono F; Ohtakara S; Morimoto I; Okamoto S; Nagataki S
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):513-8. PubMed ID: 3321820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New immunomodulators in the treatment of Graves' ophthalmopathy.
    Salvi M; Vannucchi G; Campi I; Currò N; Beck-Peccoz P
    Ann Endocrinol (Paris); 2008 Apr; 69(2):153-6. PubMed ID: 18417090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2005 Apr; 15(4):358-63. PubMed ID: 15876160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.
    Kendall-Taylor P; Crombie AL; Stephenson AM; Hardwick M; Hall K
    BMJ; 1988 Dec; 297(6663):1574-8. PubMed ID: 2906260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism.
    Manso PG; Furlanetto RP; Wolosker AM; Paiva ER; de Abreu MT; Maciel RM
    Thyroid; 1998 Jan; 8(1):49-52. PubMed ID: 9492153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of malignant Graves' ophthalmopathy with cyclosporin-A--a case report.
    Bakó G; Forizs E; Herczeg L; Kolozsvari L; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):574-6. PubMed ID: 3441606
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes.
    Kao SC; Kendler DL; Nugent RA; Adler JS; Rootman J
    Arch Ophthalmol; 1993 Jun; 111(6):819-23. PubMed ID: 8512483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computerized tomography of the orbits. A report of 196 patients.
    Nikoskelainen E; Enzmann DR; Sogg RL; Rosenthal AR
    Acta Ophthalmol (Copenh); 1977 Dec; 55(6):885-900. PubMed ID: 579543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
    Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM
    Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Course of proptosis in patients with Graves' disease after endoscopic orbital decompression.
    Ulualp SO; Massaro BM; Toohill RJ
    Laryngoscope; 1999 Aug; 109(8):1217-22. PubMed ID: 10443822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation.
    Alp MN; Ozgen A; Can I; Cakar P; Gunalp I
    Br J Ophthalmol; 2000 Sep; 84(9):1027-30. PubMed ID: 10966959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical studies of the reactivity of serum IgG from patients with Graves' ophthalmopathy with porcine orbital tissue preparations.
    Pope RM; McGregor AM
    Biomed Pharmacother; 1989; 43(8):573-9. PubMed ID: 2631976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle.
    Forbes G; Gorman CA; Brennan MD; Gehring DG; Ilstrup DM; Earnest F
    AJNR Am J Neuroradiol; 1986; 7(4):651-6. PubMed ID: 3088943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three wall orbital decompression for Graves' ophthalmopathy via a coronal approach.
    Leatherbarrow B; Lendrum J; Mahaffey PJ; Noble JL; Kwartz J; Davies H
    Eye (Lond); 1991; 5 ( Pt 4)():456-65. PubMed ID: 1743362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive treatment of Graves' ophthalmopathy with cyclosporine A.
    Utech C; Wulle KG; Panitz N; Kiefer H
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):173-7. PubMed ID: 3381272
    [No Abstract]   [Full Text] [Related]  

  • 39. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.
    Erickson BA; Harris GJ; Lewandowski MF; Murray KJ; Massaro BM
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):651-60. PubMed ID: 7852132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current imaging methods in Graves' ophthalmopathy].
    Szúcs-Farkas Z; Galuska L; Nagy VE
    Orv Hetil; 2004 Apr; 145(17):891-9. PubMed ID: 15170966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.